Laurion Capital Management’s Mineralys Therapeutics MLYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.8M | Sell |
1,762,582
-135,602
| -7% | -$1.83M | 0.43% | 6 |
|
|
2025
Q1 | $30.1M | Buy |
1,898,184
+485,795
| +34% | +$7.71M | 0.76% | 12 |
|
|
2024
Q4 | $17.4M | Hold |
1,412,389
| – | – | 0.32% | 18 |
|
|
2024
Q3 | $17.1M | Sell |
1,412,389
-44,415
| -3% | -$538K | 0.23% | 16 |
|
|
2024
Q2 | $17M | Buy |
1,456,804
+152,588
| +12% | +$1.79M | 0.2% | 33 |
|
|
2024
Q1 | $16.8M | Buy |
1,304,216
+148,148
| +13% | +$1.91M | 0.14% | 55 |
|
|
2023
Q4 | $9.94M | Buy |
1,156,068
+186,090
| +19% | +$1.6M | 0.08% | 53 |
|
|
2023
Q3 | $9.22M | Buy |
969,978
+289,847
| +43% | +$2.76M | 0.06% | 65 |
|
|
2023
Q2 | $11.6M | Buy |
680,131
+4,995
| +0.7% | +$85.2K | 0.06% | 46 |
|
|
2023
Q1 | $10.6M | Buy |
+675,136
| New | +$10.6M | 0.07% | 44 |
|